Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$23,869,814
+$3,484,477 QoQ
Shares Held
94,857
+1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#555
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Heritage Trust Co holds $93,088,717 across 10 Drug Manufacturers - General names. ABBV ranks #2 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,585 | $43,323,472 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
94,857 | $23,869,814 | |
| 3 | MRK |
Merck & Co., Inc.
|
84,905 | $10,910,292 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
44,113 | $5,573,236 | |
| 5 | LLY |
ELI LILLY & Co
|
3,959 | $4,748,543 | |
| 6 | PFE |
Pfizer Inc
|
72,085 | $1,735,806 | |
| 7 | AMGN |
Amgen Inc
|
3,893 | $1,409,733 | |
| 8 | GSK |
GSK plc
|
12,641 | $662,641 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,869,814 | 94,857 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $20,385,337 | 93,730 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $21,670,448 | 94,842 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $21,845,799 | 94,350 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,472,660 | 88,744 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $18,799,810 | 89,728 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $16,606,775 | 93,454 | Shares | Other | 2025-02-13 | |
| 2024-06-30 | $15,439,200 | 90,014 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $16,150,812 | 88,692 | Shares | Other | 2024-05-10 | |
| 2023-12-31 | $13,845,174 | 89,341 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $13,133,377 | 88,108 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $12,046,478 | 89,412 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $14,177,235 | 88,958 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,291,493 | 88,432 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $11,796,923 | 87,899 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $13,378,065 | 87,347 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $14,529,107 | 89,625 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $12,173,407 | 89,907 | Shares | Other | 2022-02-09 | |
| 2021-09-30 | $9,175,529 | 85,061 | Shares | Other | 2021-11-09 | |
| 2021-06-30 | $9,188,043 | 81,570 | Shares | Other | 2021-08-09 | |
| 2021-03-31 | $8,947,628 | 82,680 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $8,872,877 | 82,808 | Shares | Other | 2021-02-11 | |
| 2020-09-30 | $7,332,421 | 83,713 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $8,438,963 | 85,954 | Shares | Other | 2020-08-04 | |
| 2020-03-31 | $6,581,139 | 86,378 | Shares | Other | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||